Stay updated on BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Sign up to get notified when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.

Latest updates to the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3, indicating a site version update.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This is a metadata/version change with no changes to study content or user-facing information.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated to v3.4.2; the older government-funding notice (v3.4.1) and its operating-status messaging were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and guidance to status updates. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check68 days agoChange DetectedThe page now includes a glossary toggle and updated QC metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). The previous version displayed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page now displays a new revision line 'Revision: v3.3.4' and removes the previous 'Revision: v3.3.3'; no other content appears to be affected.SummaryDifference0.0%

Stay in the know with updates to BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.